These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8349933)

  • 1. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract.
    Nelson HS; Oppenheimer J; Vatsia GA; Buchmeier A
    J Allergy Clin Immunol; 1993 Aug; 92(2):229-36. PubMed ID: 8349933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of oral immunotherapy with standardized cat extract.
    Oppenheimer J; Areson JG; Nelson HS
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):61-7. PubMed ID: 8308183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study.
    Alvarez-Cuesta E; Berges-Gimeno P; González-Mancebo E; Fernández-Caldas E; Cuesta-Herranz J; Casanovas M
    Allergy; 2007 Jul; 62(7):810-7. PubMed ID: 17573730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sublingual immunotherapy with cat epithelial extract. Personal experience].
    Sánchez Palacios A; Schamann F; García JA
    Allergol Immunopathol (Madr); 2001; 29(2):60-5. PubMed ID: 11450599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial.
    Varney VA; Edwards J; Tabbah K; Brewster H; Mavroleon G; Frew AJ
    Clin Exp Allergy; 1997 Aug; 27(8):860-7. PubMed ID: 9291281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for cat asthma.
    Van Metre TE; Marsh DG; Adkinson NF; Kagey-Sobotka A; Khattignavong A; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1988 Dec; 82(6):1055-68. PubMed ID: 2462581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract.
    Nanda A; O'connor M; Anand M; Dreskin SC; Zhang L; Hines B; Lane D; Wheat W; Routes JM; Sawyer R; Rosenwasser LJ; Nelson HS
    J Allergy Clin Immunol; 2004 Dec; 114(6):1339-44. PubMed ID: 15577832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.
    La Rosa M; Ranno C; André C; Carat F; Tosca MA; Canonica GW
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):425-32. PubMed ID: 10452766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with cat- and dog-dander extracts. II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study.
    Hedlin G; Graff-Lonnevig V; Heilborn H; Lilja G; Norrlind K; Pegelow KO; Sundin B; Løwenstein H
    J Allergy Clin Immunol; 1986 Mar; 77(3):488-96. PubMed ID: 2419383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study.
    Alvarez-Cuesta E; Cuesta-Herranz J; Puyana-Ruiz J; Cuesta-Herranz C; Blanco-Quirós A
    J Allergy Clin Immunol; 1994 Mar; 93(3):556-66. PubMed ID: 8151058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract.
    Horst M; Hejjaoui A; Horst V; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1990 Feb; 85(2):460-72. PubMed ID: 2406323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy decreases skin sensitivity to cat extract.
    Van Metre TE; Marsh DG; Adkinson NF; Kagey-Sobotka A; Khattignavong A; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1989 May; 83(5):888-99. PubMed ID: 2654256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.
    Purello-D'Ambrosio F; Gangemi S; Isola S; La Motta N; Puccinelli P; Parmiani S; Savi E; Ricciardi L
    Allergy; 1999 Sep; 54(9):968-73. PubMed ID: 10505460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with cat- and dog-dander extracts. III. Allergen-specific immunoglobulin responses in a 1-year double-blind placebo study.
    Løwenstein H; Graff-Lonnevig V; Hedlin G; Heilborn H; Lilja G; Norrlind K; Pegelow KO; Sundin B
    J Allergy Clin Immunol; 1986 Mar; 77(3):497-505. PubMed ID: 2419384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.
    Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S
    J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment.
    Hedlin G; Graff-Lonnevig V; Heilborn H; Lilja G; Norrlind K; Pegelow K; Sundin B; Lowenstein H
    J Allergy Clin Immunol; 1991 May; 87(5):955-64. PubMed ID: 2026846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of ALLERVAX CAT in cat allergic patients.
    Maguire P; Nicodemus C; Robinson D; Aaronson D; Umetsu DT
    Clin Immunol; 1999 Dec; 93(3):222-31. PubMed ID: 10600332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.